Nizatidine

In the US, Nizatidine (nizatidine systemic) is a member of the drug class H2 antagonists and is used to treat Duodenal Ulcer, Duodenal Ulcer Prophylaxis, Erosive Esophagitis, GERD, Indigestion and Stomach Ulcer.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A02BA04

CAS registry number (Chemical Abstracts Service)

0076963-41-2

Chemical Formula

C12-H21-N5-O2-S2

Molecular Weight

331

Therapeutic Categories

Gastric acid secretion inhibitor

Histamine H₂-receptor antagonist

Treatment of peptic ulcer and gastro-oesophageal reflux disease (GORD)

Chemical Name

1,1-Ethenediamine, N-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-N'-methyl-2-nitro-

Foreign Names

Generic Names

  • Nizatidina (OS: DCIT)
  • Nizatidine (OS: BAN, USAN, JAN, DCF)
  • LY 139037 (IS: Lilly)
  • Nizatidin (PH: Ph. Eur. 7)
  • Nizatidine (PH: BP 2011, Ph. Eur. 7, USP 34)
  • Nizatidinum (PH: Ph. Eur. 7)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)